Want to know more about our UCB DCTx Startup Program?
We partner with healthcare’s most talented startups to generate pioneering innovations that enable patients with severe and chronic diseases to enjoy better and healthier lives.
DCTx Goals
IMMUNOLOGY
Osteoporosis
Osteoporosis
We aim to prevent secondary fragility fractures
Axial
Spondyloarthritis
Spondyloarthritis
We aim to reduce the delay in diagnosis
Psoriasis
Psoriatic arthritis
Psoriatic arthritis
We aim to accelerate the path to disease control
Hidradenitis Suppurativa
We aim to reduce the delay in diagnosis
Flamingo (IB Lab)
A radiology solution powered by UCB's BoneBot artificial intelligence (AI) model that opportunistically screens CT scans, taken for other reasons, for the presence of vertebral fractures. Vertebral fractures are powerful predictor of further fractures.
FASTRAX
The FASTRAX program is focusing on the lengthy and challenging journey of diagnosing Axial Spondyloarthritis (axSpA). Through innovative digital solutions and strategic collaborations, our initiatives in UK, Canada, France and the US address different unmet needs for patients and healthcare providers.
Bingli
Bingli delivers person-centered, digital health solutions through AI-powered, intelligent medical history and patient assessments. Our self-learning, situationally aware virtual patient engagement system supports both patients and healthcare professionals. By asking smart questions, we aid in triage, diagnosis, and care navigation, ensuring efficient and effective care by the right provider at the right time.
DCTx Goals
NEUROLOGY
Epilepsy
We aim to elevate the coordination of care and enhance outcomes with novel solutions (including seizure prediction)
Rare diseases
We aim to support patients on their disease journey and help earlier diagnosis
Huma MG
The Huma MG Solution empowers patients through self-monitoring, providing their healthcare providers with crucial health data needed to facilitate a new level of personalized and effective support.
Neurava
Neurava is developing novel wearables to monitor and alert for seizures and any induced cardiorespiratory dysfunctions to potentially mitigate Sudden Unexpected Death in Epilepsy (SUDEP) risk by enabling life-saving intervention from caregivers. Captured data will enable SUDEP risk stratification by physicians, potentially enabling more effective treatment plans.
CareCompass
Recognizing the need for a unified platform to streamline the care of individuals with rare epilepsies, we have co-developed CareCompass with input from caregivers. This innovative, cost-free digital solution is specifically designed to support caregivers of loved ones living with Dravet syndrome (DS) or Lennox-Gastaut syndrome (LGS). CareCompass consolidates caregiving tasks into one accessible platform, empowering caregivers to efficiently manage patient information, medications, emergency plans, and daily routines—all in one place. The platform can be accessed via the web and is currently available to residents of the United States.
TRANSVERSAL
BlueHealth Innovation Fund
We invested in the BHIF to identify and support early-stage future leading health tech companies.